What is Filana Therapeutics, Inc. Common Stock's Market Cap?

Filana Therapeutics, Inc. Common Stock's Market Cap is $39.6M, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's Enterprise Value?

Filana Therapeutics, Inc. Common Stock's Enterprise Value is -$43.1M, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's EV / EBITDA?

Filana Therapeutics, Inc. Common Stock's EV / EBITDA is 1.0×, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's Net Income (TTM)?

Filana Therapeutics, Inc. Common Stock's Net Income (TTM) is -$42.3M, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's EBITDA?

Filana Therapeutics, Inc. Common Stock's EBITDA is -$45.0M, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Filana Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.88, based on as-reported figures from SEC (XBRL) filings.

What is Filana Therapeutics, Inc. Common Stock's Net Debt?

Filana Therapeutics, Inc. Common Stock's Net Debt is -$82.7M, based on as-reported figures from SEC (XBRL) filings.

Filana Therapeutics, Inc. Common Stock (FLNA) Financial Statements

Filana Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SCKXX9

XNAS · usd

0.82▲ 0.02 (2.86%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.80

Day's Range0.75 – 0.82

52-Week Range0.75 – 2.40

Volume509.4K

Avg Volume273.0K

Share Statistics

Shares Outstanding

Employees20

ExchangeXNAS

Listed2000-07-14

Share count as of July 27, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Filana Therapeutics, Inc. Common Stock (FLNA)

What is Filana Therapeutics, Inc. Common Stock's Market Cap?: Filana Therapeutics, Inc. Common Stock's Market Cap is $39.6M, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's Enterprise Value?: Filana Therapeutics, Inc. Common Stock's Enterprise Value is -$43.1M, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's EV / EBITDA?: Filana Therapeutics, Inc. Common Stock's EV / EBITDA is 1.0×, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's Net Income (TTM)?: Filana Therapeutics, Inc. Common Stock's Net Income (TTM) is -$42.3M, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's EBITDA?: Filana Therapeutics, Inc. Common Stock's EBITDA is -$45.0M, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Filana Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.88, based on as-reported figures from SEC (XBRL) filings.
What is Filana Therapeutics, Inc. Common Stock's Net Debt?: Filana Therapeutics, Inc. Common Stock's Net Debt is -$82.7M, based on as-reported figures from SEC (XBRL) filings.